DUSP22 and neoplasm: TC-1 tumor growth in DUSP22-deficient mice showed no significant difference compared to WT mice (Fig. 3G), suggesting that DUSP22 ablation in immune cells or stromal cells does not significantly promote lung tumor growth in vivo.